NeuShen Therapeutics Closes Series A Funding for CNS Disorder Drug Development
NeuShen Therapeutics, a biotech company with operations in Shanghai, China, and Boston, Massachusetts, has closed...
NeuShen Therapeutics
NeuShen Therapeutics and Livzon Pharma Strike Deal for Greater China Rights to NS-041
NeuShen Therapeutics, a Sino-US biopharmaceutical company, has entered into a licensing agreement with Livzon Pharmaceutical...
HealZen Therapeutics and NeuShen Seal Deal for Global Rights to CNS Drug Programs
China-based HealZen Therapeutics has entered into a licensing agreement with compatriot firm NeuShen, focusing on...
NeuShen Therapeutics Partners with UMass Chan for ALS Gene Therapy Development
Sino-US biotech firm NeuShen Therapeutics Inc., focused on central nervous system (CNS) disorders, has announced...
NeuShen Therapeutics Closes $20M Series Pre-A Financing for CNS Drug Development
NeuShen Therapeutics has announced the successful closure of a $20 million Series pre-A financing round...